Long-Term Remission Achieved by Ponatinib and Donor Lymphocytes Infusion in a Ph+ Acute Lymphoblastic Leukemia Patient in Molecular Relapse After Allogenic Stem Cell Transplant and Dasatinib: A Case Report

Currently, the prognosis of Ph+ acute lymphoblastic leukemia (Ph+ ALL) patients relapsing after an allogenic hematopoietic stem cell transplantation (allo-SCT) remains poor, with few therapeutic options available. Here we present the case of a 32 years old patient with dasatinib-resistant post-trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Botta, Cirino, Caruso, Nadia, Bossio, Sabrina, Storino, Francesca, Console, Giuseppe, Martino, Massimo, Mendicino, Francesco, Lucia, Eugenio, Morelli, Rosellina, Correale, Pierpaolo, Morabito, Fortunato, Gentile, Massimo, Vigna, Ernesto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314974/
https://www.ncbi.nlm.nih.gov/pubmed/32626658
http://dx.doi.org/10.3389/fonc.2020.00967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314974/
https://www.ncbi.nlm.nih.gov/pubmed/32626658
http://dx.doi.org/10.3389/fonc.2020.00967

Ejemplares similares